The safety profile of Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y tetanus toxoid conjugate vaccine (HibMenCY)

Human Vaccines and Immunotherapeutics

Volumn 8, Issue 3, 2012, Pages 294-301

  Rinderknecht, Stephen ^a   Bryant, Kristina ^b   Nolan, Terry ^c   Pavia Ruz, Noris ^d   Doniz, Carlos Aranza ^e   Weber, Miguel Angel Rodriguez ^f   Cohen, Christopher ^g   Aris, Emmanuel ^h   Mesaros, Narcisa ^h   Miller, Jacqueline M ^g  

^a Iowa Health Physicians   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^e Centro Medico Lic Adolfo Lopez Mateos   (Mexico)

^f INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

^g GLAXOSMITHKLINE   (United States)

^h GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

Adverse drug event; Haemophilus influenzae type b; Neisseria meningitidis; Vaccine

Indexed keywords

BACTERIAL VACCINE; CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HEPATITIS B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B NEISSERIA MENINGITIDIS SEROGROUP C AND Y TETANUS TOXOID CONJUGATE VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MEASLES MUMPS RUBELLA VACCINE; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ADVERSE OUTCOME; ALLERGIC RHINITIS; ANEMIA; ANOREXIA; ARTICLE; ASTHMA; ATAXIA; ATOPIC DERMATITIS; BRAIN HEMORRHAGE; BRONCHIOLITIS; BRONCHOPNEUMONIA; BRONCHUS HYPERREACTIVITY; CEREBELLAR ATAXIA; CLINICAL EFFECTIVENESS; CONSCIOUSNESS DISORDER; CONSTIPATION; CONTACT DERMATITIS; CONVULSION; COUGHING; CROUP; CRYING; DEHYDRATION; DERMATITIS; DIAPER DERMATITIS; DIARRHEA; DROWSINESS; DRUG APPROVAL; DRUG CONJUGATION; DRUG EFFECT; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MONITORING; DRUG SAFETY; ECZEMA; EPILEPSY; ERYTHEMA; FEBRILE CONVULSION; FEVER; FOLLOW UP; FOOD ALLERGY; GASTROENTERITIS; GASTROESOPHAGEAL REFLUX; HUMAN; INFANTILE SPASM; INJECTION SITE ERYTHEMA; INJECTION SITE IRRITATION; INJECTION SITE PAIN; INJECTION SITE SWELLING; INSOMNIA; IRRITABILITY; MILK ALLERGY; MUSCLE HYPOTONIA; NEUROLOGIC DISEASE; NOSE CONGESTION; NYSTAGMUS; OTITIS MEDIA; OUTCOME ASSESSMENT; PAPULAR RASH; PETECHIA; PNEUMONIA; PRIMARY PREVENTION; PURPURA; RASH; RHINORRHEA; SEBORRHEIC DERMATITIS; SIDE EFFECT; SUDDEN INFANT DEATH SYNDROME; TOOTH ERUPTION; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; URTICARIA; VACCINATION; VIRAL BRONCHIOLITIS; VIRAL GASTROENTERITIS; VIRUS INFECTION; VOMITING;

EID: 84860381633     PISSN: None     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.8.3.18752     Document Type: Article

References (9)

1. Cohn AC, MacNeil JR, Harrison LH, Hatcher C, Theodore J, Schmidt M, et al. Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease. Clin Infect Dis 2010; 50:184-91; PMID:20001736; http://dx.doi.org/10.1086/649209
2. FDA - Menactra approval letter April 22, 2011. http://www.fda.gov/ BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm252511.htm. Accessed June 8, 2011.
3. WHO position paper on Haemophilus influenzae type b conjugate vaccines. Wkly Epidemiol Rec 2006; 81:445-52; PMID:17124755
4. Marchant CD, Miller JM, Marshall GS, Blatter M, Aris E, Friedland LR, et al. Randomized trial to assess immunogenicity and safety of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in infants. Pediatr Infect Dis J 2010; 29:48-52; PMID:20035207; http://dx.doi.org/10.1097/INF.0b013e3181c3ce88
5. Marshall GS, Marchant CD, Blatter M, Aris E, Boutriau D, Poolman JT, et al. Immune response and one-year antibody persistence after a fourth dose of a novel Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine (HibMenCY) at 12 to 15 months of age. Pediatr Infect Dis J 2010; 29:469-71; PMID:20072077; http://dx.doi.org/10.1097/INF. 0b013e3181cdd379
6. Nolan T, Lambert S, Roberton D, Marshall H, Richmond P, Streeton C, et al. A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants. Vaccine 2007; 25:8487-99; PMID:17996996; http://dx.doi.org/10.1016/j.vaccine.2007.10.013
7. Nolan T, Richmond P, Marshall H, McVernon J, Alexander K, Mesaros N, et al. Immunogenicity and safety of an investigational combined Haemophilus influenzae type B-Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine. Pediatr Infect Dis J 2011; 30:190-6; PMID:20948453; http://dx.doi.org/10.1097/INF.0b013e3181fcb2bf
8. Bryant KA, Marshall GS, Marchant CD, Pavia-Ruiz N, Nolan T, Rinderknecht S, et al. Immunogenicity and Safety of H influenzae Type b-N meningitidis C/Y Conjugate Vaccine in Infants. Pediatrics 2011; 127:e1375-85; PMID:21624883; http://dx.doi.org/10.1542/peds.2009-2992
9. Australian Government Department of Health and Ageing, National Health and Medical Research Council. The Australian Immunisation Handbook 9th Edition 2008. http://www.health.gov.au/internet/immunise/publishing.nsf/content/ handbook-home. Accessed August 9, 2011.